30 Day Trial

ORTHOWORLD » Other Articles of Interest

Globus Medical Making Sizable Push Into Trauma Market

By Rob Meyer

In 2Q17, the leadership of Globus Medical (GMED) expressed a desire to diversify outside of spine, affirming plans for production of trauma products.

Fast-forward to the 2018 American Academy of Orthopedic Surgeons (AAOS) Annual Meeting this month, where GMED displayed its growing portfolio of FDA 510(k)-cleared trauma products in four families, including fracture plates, compression screws, cannulated screws, intramedullary nails and external fixation. Full launch of all systems will commence in 2Q18 (profit contributions of significance are expected in 2019).

Read on at BONEZONE® for more on GMED's new trauma products and for details on the company's strategic initiatives to move away from the pure-play spine label.